Registration number: 07199879

Bioscience IP Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 5

Bioscience IP Limited

Company Information

Director

Mr P C Banford

Registered office

11 Lostock Hall Road Poynton Cheshire SK12 1DP

Accountants

Bright Partnership Limited Suite 1 Armcon Business Park, London Road South Poynton Cheshire SK12 1LQ

Bioscience IP Limited

(Registration number: 07199879)
Balance Sheet as at 31 March 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	579	174
Current assets
Debtors	5	914	1,804
Cash at bank and in hand		13,951	29,598
		14,865	31,402
Creditors: Amounts falling due within one year	6	(14,432)	(30,928)
Net current assets		433	474
Total assets less current liabilities		1,012	648
Provisions for liabilities		(110)	(33)
Net assets		902	615
Capital and reserves
Called up share capital		103	103
Retained earnings		799	512
Shareholders' funds		902	615

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 August 2026
 

......................................... Mr P C Banford Director

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1	General information

Bioscience IP Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

These financial statements were authorised for issue by the director on 14 August 2026.

2	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and
Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or
directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures & Fittings	15 % Reducing Balance Method
Computer Equipments	33% Streight Line Method

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2025 - 3).

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

4	Tangible fixed assets

	Plant and machinery  £	Total £
Cost or valuation
At 1 April 2025	20,121	20,121
Additions	487	487
Disposals	(19,421)	(19,421)
At 31 March 2026	1,187	1,187
Depreciation
At 1 April 2025	19,947	19,947
Charge for the year	68	68
Eliminated on disposal	(19,407)	(19,407)
At 31 March 2026	608	608
Carrying amount
At 31 March 2026	579	579
At 31 March 2025	174	174

5	Debtors: amounts falling due within one year

	2026 £	2025 £
Trade debtors	657	1,593
Other debtors	257	211
	914	1,804

6

Creditors

Creditors: amounts falling due within one year

	2026 £	2025 £
Due within one year
Trade creditors	-	11,724
Taxation and social security	11,935	15,134
Other creditors	2,497	4,070
	14,432	30,928